Lilly’s 340B Restrictions: Jury Is Still Out On Appropriateness, But Optics Are Bad, HHS Says

Letter from department’s general counsel responds to request from the company for a pre-enforcement advisory opinion. Despite the letter, Lilly maintains its ‘limited distribution program is fully consistent with applicable laws and regulations.’

regulatory compliance concept on the gearwheels, 3D rendering
Compliance Challenge Underway In 340B Program

More from Pricing Debate

More from Market Access